Author

Roger D. Depaz

National Institutes of Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Benjamin C. BrimiD· 1 shared Carleen A. Klumpp-ThomasiD· 1 shared Cindy H. ChauiD· 1 shared Craig Thomas· 1 shared Crystal G. McKnightiD· 1 shared Elijah F. EdmondsoniD· 1 shared Erica L. BeatsoniD· 1 shared Erin BeckiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Benjamin C. BrimORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Co-Targeting Nuclear Export and Translation Initiation Uncovers a Therapeutic Vulnerability in Lethal Prostate Cancer

Jessica D. Kindrick, Kinjal P. Bhadresha, Xiaohu Zhang, Erica L. Beatson, Spencer S. Gaut, Benjamin C. Brim, Patrick J. Signorelli, Roger D. Depaz, Jessica L. Horner, Posey S Whidden, John M. Ching, Kelli Wilson, Savannah Wood, Crystal G. McKnight, Erin Beck, , William D. Figg

This study identifies co-inhibition of XPO1 and EIF4A1 as a therapeutic strategy for mCRPC, showing synergistic antitumor effects at reduced drug doses.

bioRxiv · May 7, 2026 · PreprintCancer Biology